---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-064079"
form_type: "8-K"
ticker: "GRDN"
cik: "0001802255"
company_name: "Guardian Pharmacy Services, Inc."
filed_at: "2025-03-26T23:59:59+00:00"
generated_at: "2026-05-24T05:09:09.427052+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Guardian Pharmacy Q4 revenue up 20% to $338.6M; FY net loss $71M on IPO charges

## Summary
- Q4 revenue $338.6M (+20% YoY); resident count 186,000 (+14% YoY).
- Q4 net income $11.8M (down $2.7M YoY); FY net loss $71.0M on $131.5M stock-comp from IPO/Reorg.
- Adjusted EBITDA Q4 $25.9M (+30% YoY); FY $90.8M (+19% YoY).
- No debt outstanding at year-end; $40M credit line available (expandable to $75M).
- FY2025 guidance: revenue $1.33B-$1.35B, Adj. EBITDA $97M-$101M; incl. ~$4M public co. costs.

## SEC filing metadata
- accession: 0001193125-25-064079
- form_type: 8-K
- ticker: GRDN
- cik: 0001802255
- company_name: Guardian Pharmacy Services, Inc.
- filed_at: 2025-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/0001193125-25-064079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/d843493d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-064079
- JSON: https://secwatch.observer/filing/0001193125-25-064079.json
- Plain text: https://secwatch.observer/filing/0001193125-25-064079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.